Zonisamide improves motor function in Parkinson disease: a randomized, double-blind study.
about
Endoplasmic reticulum stress and Parkinson's disease: the role of HRD1 in averting apoptosis in neurodegenerative diseaseThinking outside the cleft to understand synaptic activity: contribution of the cystine-glutamate antiporter (System xc-) to normal and pathological glutamatergic signalingSerotonin 1A Receptors on Astrocytes as a Potential Target for the Treatment of Parkinson's DiseaseAnatomical localization of Cav3.1 calcium channels and electrophysiological effects of T-type calcium channel blockade in the motor thalamus of MPTP-treated monkeysA review of the use of zonisamide in Parkinson's diseaseEffect of T-type calcium channel blockers on spiral ganglion neurons of aged C57BL/6J mice.The antiepileptic drug zonisamide inhibits MAO-B and attenuates MPTP toxicity in mice: clinical relevance.Zonisamide discontinuation due to psychiatric and cognitive adverse events: a case-control studyMedical management of Parkinson's disease: focus on neuroprotectionZonisamide attenuates α-synuclein neurotoxicity by an aggregation-independent mechanism in a rat model of familial Parkinson's diseaseProtective effect of melatonin against zonisamide-induced reproductive disorders in male ratsParkinson's Disease and Its Management: Part 3: Nondopaminergic and Nonpharmacological Treatment Options.Characteristics of the sequence effect in Parkinson's diseaseZonisamide for the treatment of Parkinson's disease.Long-term safety and effectiveness of zonisamide in the treatment of epilepsy: a review of the literature.What's in the pipeline for the treatment of Parkinson's disease?Zonisamide: a review of the clinical and experimental evidence for its use in Parkinson's diseaseT-type calcium channel as a new therapeutic target for tremor.Drug safety evaluation of zonisamide for the treatment of epilepsy.The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the motor symptoms of Parkinson's disease.The efficacy and safety of newer anticonvulsants in patients with dementia.The design and discovery of T-type calcium channel inhibitors for the treatment of central nervous system disorders.The adverse event profile of zonisamide: a meta-analysis.Non-dopaminergic treatments for motor control in Parkinson's disease.Levodopa-induced dyskinesias in Parkinson's disease: emerging treatmentsTreatment of motor fluctuations in Parkinson's disease: recent developments and future directions.The T-type calcium channel as a new therapeutic target for Parkinson's disease.Emerging drugs for levodopa-induced dyskinesia.Pharmacological strategies for the management of levodopa-induced dyskinesia in patients with Parkinson's disease.The ongoing pursuit of neuroprotective therapies in Parkinson disease.Tardive dyskinesia (syndrome): Current concept and modern approaches to its management.Treatment of the later stages of Parkinson's disease - pharmacological approaches now and in the future.Neuroprotection as a Potential Therapeutic Perspective in Neurodegenerative Diseases: Focus on Antiepileptic Drugs.New and emerging medical therapies in Parkinson's disease.Combination Therapy with Zonisamide and Antiparkinson Drugs for Parkinson's Disease: A Meta-Analysis.Tyrosine hydroxylase (TH), its cofactor tetrahydrobiopterin (BH4), other catecholamine-related enzymes, and their human genes in relation to the drug and gene therapies of Parkinson's disease (PD): historical overview and future prospects.Protective effects of zonisamide against rotenone-induced neurotoxicity.HRD1 levels increased by zonisamide prevented cell death and caspase-3 activation caused by endoplasmic reticulum stress in SH-SY5Y cells.Nightmare-enacting behavior responding to zonisamide in early Parkinson's disease.Therapeutic effect of a novel anti-parkinsonian agent zonisamide against MPTP (1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine) neurotoxicity in mice.
P2860
Q24293694-BA1C169B-7D2B-48C4-A3CA-D51D7CD9F33EQ26864995-854F8E52-5FDD-4D0C-80BC-198B3620BC34Q28079379-0A34C88B-F8A6-47E4-B6F1-A8D1F1668038Q28269449-435DAFB0-D4E0-4CCD-AC9C-85E2F6067447Q28301683-FEFBBD97-71C8-4598-B6B5-54AC06A79EB1Q30397279-BF92264A-A217-4176-94F3-8A618E96CE9AQ33615756-5EE4C5F7-C4C3-4D67-B4BA-75D93C7602CEQ34053280-342A73AF-EE7B-4083-A06F-F1C6583ED78CQ35092165-2972E908-DF22-4AB0-81A8-1F331C173888Q35106629-8D8FA661-2034-46B7-A4F5-E62718C5E775Q35829199-5055A4C3-3C18-4480-8E19-91A49B30C7E7Q36164724-BC720E41-4BE3-4293-AE4C-CA2672988104Q36663013-F0345ADB-7808-41B5-B386-FC52BB9DB0D3Q36941885-C15D72C5-3E90-4FEA-BFF5-F5611698BAAFQ37224576-9D625DC9-E114-4F96-A0FA-3C2815C4E70DQ37352050-FC6C95E8-EDBA-4BF2-A29F-4728F59D905CQ37356891-08A0220D-851B-45BA-8D61-44954149EE86Q37863576-289DC9F3-F056-446A-B466-E59E43B1AABBQ37887798-55860164-B45B-47F8-B92F-EE8B8E9FFCD2Q37948713-FD700430-F886-4ED2-BD44-3F6A8D02D9E1Q38021819-C8AE7A10-203D-4AAA-BFD1-86D0EFFFB8C9Q38105331-2E7D860C-EEA0-47DC-89AF-0F8139BEEB24Q38114131-DB8452DE-375A-4930-A8C6-A7D45E1A567DQ38126817-5515B5AC-5CE4-4EDC-AF69-B2B1282F2964Q38156760-A4DAA7FB-531B-4B3A-9356-8F5AC6EE9B1DQ38170421-5E0A6109-7C89-4029-B610-1B9243D9A22FQ38188451-A1575D5A-585A-4C9C-916E-70F1ABCA2323Q38242091-9A903F3B-0FE2-4EAA-9F8E-46A1433DA512Q38262418-16D9821F-6821-4416-8CE2-C35B598E2FA7Q38275171-2A794B75-EA34-4125-82DC-72DE0FE09435Q38306593-A38180B5-4D37-4995-AF43-F8C63FCA5589Q38478999-1021C276-9C49-4925-92F9-2703D339051AQ38684428-03682551-4FB6-4A17-A19A-E3FB5333258DQ38718194-25A075FF-FF7A-4C7C-A3B6-8CBC8549C64FQ38762146-E9CFB236-C696-4C57-88E3-21DE04AE88D0Q38834545-CFB9FB93-683A-4D56-B2B9-D2408DF00E61Q39076196-7BA7E57B-29AA-4F50-84A1-87423F79924BQ39479487-CBC47227-6F33-4CD9-8594-72CBEBC26F83Q42133545-7F42D542-76D8-4AD9-9963-99F5D6550461Q42854732-E2312B9B-10A7-4A3B-8996-C64FC5293CE2
P2860
Zonisamide improves motor function in Parkinson disease: a randomized, double-blind study.
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Zonisamide improves motor func ...... andomized, double-blind study.
@ast
Zonisamide improves motor func ...... andomized, double-blind study.
@en
Zonisamide improves motor func ...... andomized, double-blind study.
@nl
type
label
Zonisamide improves motor func ...... andomized, double-blind study.
@ast
Zonisamide improves motor func ...... andomized, double-blind study.
@en
Zonisamide improves motor func ...... andomized, double-blind study.
@nl
prefLabel
Zonisamide improves motor func ...... andomized, double-blind study.
@ast
Zonisamide improves motor func ...... andomized, double-blind study.
@en
Zonisamide improves motor func ...... andomized, double-blind study.
@nl
P2093
P1433
P1476
Zonisamide improves motor func ...... andomized, double-blind study.
@en
P2093
Ichiro Kanazawa
Japan Zonisamide on PD Study Group
Kazuko Hasegawa
Miho Murata
P356
10.1212/01.WNL.0000250236.75053.16
P407
P577
2007-01-01T00:00:00Z